一级组1 前列腺癌表现出瘤定义的雄激素受体驱动程序
Simon Linder1, Tesa M Severson2, Koen J C van der Mijn3
1Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
European urology
|June 4, 2023
概括
低度前列腺癌 (GG1) 显示了由雄激素受体 (AR) 驱动的独特分子活性,证实了它们被归类为真正的癌症. 这些发现使它们与非癌性前列腺组织有所区别.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 1级 (GG1) 前列腺癌 (格里森得分6) 是低转移风险的惰性,促使人们对其癌症分类进行辩论.
- 这些低度瘤中的分子驱动因素,特别是雄激素受体 (AR),尚未完全理解.
- 鉴定AR活性对于区分低度癌症和良性前列腺组织至关重要.
研究的目的:
- 在GG1前列腺癌中划分雄激素受体 (AR) 染色质结合格局.
- 为了调查GG1瘤中AR驱动的分子程序是否具有瘤特异性或类似于正常的前列腺上皮.
- 为低度前列腺癌的分类提供表观遗传的见解.
主要方法:
- 染色体免疫沉测序 (ChIP-seq) 用于绘制AR结合部位的地图.
- 对 cis 调节元件和增强剂活性进行分析.
- 对AR目标基因的基因表达概况.
主要成果:
- 与更高级癌症相比,GG1瘤没有表现出明显的AR囊瘤.
- 在GG1瘤中,AR优先结合于定义瘤的cis-regulatory元素.
- 增强剂活性和向基因表达仍然与更高等级的癌症相似,将其与良性组织区分开来.
结论:
- 表观遗传特征支持GG1前列腺瘤的癌症指定.
- 在GG1瘤中,AR驱动的分子活性是瘤特异性的,与良性前列腺上皮质不同.
- 这些发现澄清了低度前列腺癌的生物性质.
关键词:
雄激素受体的受体 雄激素受体表观基因组学是指表观基因组学.格里森的分级是什么国际泌尿病学病理学会等级组.前列腺癌是什么意思 前列腺癌是什么意思文字转录学 (Transcriptomics) 是一个学科.更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
11.2K
相关概念视频
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K